B. Muzyka

PREVLAR: Phase 2a randomized trial to assess the safety and efficacy of RRx-001 in the attenuation of oral mucositis in patients receiving head and neck chemoradiotherapy.

K. Niermann, D. Sher, M. Biagioli, 2023, International journal of radiation oncology, biology, physics.